Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.
Vijay Patil, Kumar Prabhash(Homi Bhabha National Institute), Aparna Manjrekar, Atanu Bhattacharjee, Vanita Noronha, Sarbani Ghosh Laskar(Tata Memorial Hospital), Vijayalakshmi Mathrudev, Vedang Murthy(Homi Bhabha National Institute), Pankaj Chaturvedi(Tata Memorial Hospital), Amit Joshi(Dr. Rajendra Prasad Government Medical College), Devendra Chaukar(Tata Memorial Hospital), Shripad Banavali(Tata Memorial Hospital), Ashwini Budrukkar(Tata Memorial Hospital), Sadhana Kannan(Homi Bhabha National Institute), Jaiprakash Agarwal(Tata Memorial Hospital), Kavita Nawale, Anil D′Cruz(Apollo Hospitals), Arti Bhelekar(Homi Bhabha National Institute), S Juvekar(Tata Memorial Hospital), Prathamesh Pai(Tata Memorial Hospital)
Cited by 11
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
|Journal of Clinical Oncology|2015|459
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Preferred reporting of case series in surgery; the PROCESS guidelines
|International Journal of Surgery|2016|384